Ossium Health and Extremity Medical Create Strategic Partnership for Nationwide Distribution of OssiGraft Viable Bone Matrix
The product is derived from a younger donor demographic than other bone allografts on the market and is characterized by a high cancellous bone ratio for optimal bone healing.
- The product is derived from a younger donor demographic than other bone allografts on the market and is characterized by a high cancellous bone ratio for optimal bone healing.
- "Extremity Medical shares Ossium's ambition to apply engineering principles in developing creative solutions that enhance human health.
- Extremity Medical also announced the successful completion of the initial cases with OssiGraft.
- To learn more about OssiGraft Viable Bone Matrix, please visit: www.extremitymedical.com